Ryvu Therapeutics SA's market cap is currently €145.65M. The company's EPS TTM is €-0.341689712; its P/E ratio is ―; Ryvu Therapeutics SA is scheduled to report earnings on September 11, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
